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Auditory verbal hallucinations (AVHs) are a hallmark of schizophrenia and can signifi-
cantly impair patients’ emotional, social, and occupational functioning. Despite progress 
in psychopharmacology, over 25% of schizophrenia patients suffer from treatment-re-
sistant hallucinations. In the search for alternative treatment methods, neurofeedback 
(NF) emerges as a promising therapy tool. NF based on real-time functional magnetic 
resonance imaging (rt-fMRI) allows voluntarily change of the activity in a selected brain 
region  –  even in patients with schizophrenia. This study explored effects of NF on 
ongoing AVHs. The selected participants were trained in the self-regulation of activity 
in the anterior cingulate cortex (ACC), a key monitoring region involved in generation 
and intensity modulation of AVHs. Using rt-fMRI, three right-handed patients, suffering 
from schizophrenia and ongoing, treatment-resistant AVHs, learned control over ACC 
activity on three separate days. The effect of NF training on hallucinations’ severity 
was assessed with the Auditory Vocal Hallucination Rating Scale (AVHRS) and on the 
affective state – with the Positive and Negative Affect Schedule (PANAS). All patients 
yielded significant upregulation of the ACC and reported subjective improvement in 
some aspects of AVHs (AVHRS) such as disturbance and suffering from the voices. 
In general, mood (PANAS) improved during NF training, though two patients reported 
Abbreviations: ACC, anterior cingulate cortex; AC–PC, anterior commissure–posterior commissure; AVHRS, Auditory 
Vocal Hallucination Rating Scale; AVHs, auditory verbal hallucinations; BOLD, blood-oxygen-level dependent; DBS, deep 
brain stimulation; DSM-IV, diagnostic and statistical manual of mental disorders, 4th edition; ECT, electroconvulsive therapy; 
EEG, electroencephalography; EPI, echo planar imaging; FEW, family-wise error; MNI, Montreal Neurological Institute; NF, 
neurofeedback; PANAS, Positive and Negative Affect Schedule; PANSS, Positive and Negative Syndrome Scale; PTSD, post-
traumatic stress disorder; ROI, region of interest; rt-fMRI, real-time functional magnetic resonance imaging; rTMS, repetitive 
transcranial magnetic stimulation; SCID-I, structured clinical interview-axis I; SPM, statistical parametric mapping; STG, 
superior temporal gyrus; tDCS, transcranial direct current stimulation; TR, repetition time.
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INtRoDUCtIoN
Auditory verbal hallucinations (AVHs) are a hallmark of 
schizophrenia and affect approximately 60–80% of patients with 
schizophrenia (1). They encompass a range of experiences: single 
or multiple voices; familiar to the patient or unknown; speaking 
sequentially or simultaneously; speaking in the first, second, or 
third person; giving commands, comments, insults, or encour-
agement (2). AVHs constitute a significant persisting burden 
for the patients (3) and are typically associated with social and 
occupational dysfunction (4) as well as worse prognosis (5). A 
large meta-analysis (6) revealed that only 14% of individuals with 
schizophrenia fully recover over 10 years. The rest will suffer from 
negative and positive symptoms as well as cognitive deficits of 
varying intensity.
Although antipsychotic medication rapidly reduces the fre-
quency and severity of hallucinations in the majority of patients (7), 
AVHs are refractory to traditional antipsychotic drugs in 25–30% 
of cases (4). Psychosocial treatments, including cognitive behavio-
ral therapy, are often applied as an augmentation to pharmacologi-
cal treatment, helping to reduce the emotional distress associated 
with AVHs and aiming at developing new coping strategies (7). 
However, they rarely change the frequency of hallucinations and 
moreover, many patients do not manage to engage in therapy (4). 
Another neuromodulatory method, electroconvulsive therapy 
(ECT), failed to show a specific reduction in hallucination severity 
(7). In a similar vein, the effectiveness of repetitive transcranial 
magnetic stimulation (rTMS) is still highly controversial (8–10). 
Consequently, AVHs remain one of the central targets in treatment 
of schizophrenia, including experimental therapies [e.g., Ref. (11)].
Neurofeedback (NF) based on real-time functional magnetic 
resonance imaging (rt-fMRI) is a newly emerging technique with 
high potential for clinical applications in psychiatric disorders 
(12, 13). It allows subjects to voluntarily change the activity in 
a selected brain region [for a review, see Ref. (14, 15)] and elicit 
behavioral changes [for a review, see Ref. (16)]. In the first study 
applying fMRI-based NF in schizophrenia, nine patients learned 
to regulate their hemodynamic response in bilateral anterior 
insula (17). The training improved patients’ abilities to recognize 
disgust faces, but they were less accurate in recognition of happy 
faces. Although the study did not focus on clinical improvement, 
it showed patients’ ability to learn volitional brain control using 
rt-fMRI. A clinical improvement in positive and negative symp-
toms of schizophrenia was demonstrated in electroencephalog-
raphy (EEG)-guided NF, with its effects evoking long-lasting 
results confirmed in a 2-year follow-up (18). fMRI-based NF 
has the potential for higher specificity and has been suggested as 
experimental treatment for AVH in addition to and in combina-
tion with its EEG-based counterpart (11).
To determine the underlying pathophysiology, neuroimaging 
studies on AVHs in schizophrenia have been carried out for 
over 25 years, demonstrating an involvement of a wide network 
of brain areas including secondary (and occasionally primary) 
sensory cortices, prefrontal and premotor cortex, anterior cin-
gulate cortex (ACC), as well as subcortical and cerebellar regions 
[for a review, see Ref. (3, 19)]. Among them, the ACC has a key 
role in regulating emotions, goal-directed behaviors, attentional 
processes, response selection, online source monitoring, and 
cognitive control (20, 21). Moreover, the ACC is involved in dif-
ferentiating between self- and not self-related stimuli (22), plac-
ing it as a good candidate to differentiate between inner speech 
and external stimulation. Furthermore, a recent meta-analysis 
on AVHs demonstrated decreased ACC activity in hallucinating 
as compared to non-hallucinating schizophrenia patients and 
healthy subjects (23). Although other brain regions, such as the 
superior temporal gyrus [STG (24, 25)] or the inferior frontal 
gyrus [Broca’s area (24)], may be equally important in psychopa-
thology of AVH, we chose ACC as a target region for our study. 
First, the ACC has shown feasibility for NF studies in healthy 
subjects (26–31) and even in patients with schizophrenia (32, 
33). Second, our research group has expertise in fMRI NF of this 
region, e.g., the successful upregulation of the rostral ACC was 
associated with increase in positive affect (27, 31) and improve-
ment of emotional perception of voices (27).
Within the current study, we aimed to explore feasibility and 
the variability of effects of ACC regulation on AVHs. Therefore, 
worse mood after NF on the third day. ACC and reward system activity during NF learn-
ing and specific effects on mood and symptoms varied across the participants. None of 
them profited from the last training set in the prolonged three-session training. Moreover, 
individual differences emerged in brain networks activated with NF and in symptom 
changes, which were related to the patients’ symptomatology and disease history. NF 
based on rt-fMRI seems a promising tool in therapy of AVHs. The patients, who suffered 
from continuous hallucinations for years, experienced symptom changes that may be 
attributed to the NF training. In order to assess the effectiveness of NF as a therapeutic 
method, this effect has to be studied systematically in larger groups; further, long-term 
effects need to be assessed. Particularly in schizophrenia, future NF studies should take 
into account the individual differences in reward processing, fatigue, and motivation to 
develop individualized training protocols.
Keywords: schizophrenia, auditory hallucinations, functional magnetic resonance imaging, neurofeedback, 
brain–computer interface, self-regulation, anterior cingulate cortex, affect
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three patients with schizophrenia, suffering from treatment-
resistant AVHs, learned voluntary control over ACC activity 
using fMRI-based NF. We expected that successful upregulation 
will lead to a decrease in severity of AVHs, to improvement of 
psychopathology, particularly concerning positive symptoms, 
and to an increased valence of the perceived voices [in accordance 
with Ref. (27)].
MateRIaLs aND MetHoDs
participants
Three right-handed patients with schizophrenia who suffered 
from different types of treatment-resistant AVHs participated as 
pilot subjects in the study. All three patients were diagnosed with 
schizophrenia according to the Structured Clinical Interview 
for DSM-IV-axis I disorders [SCID-I (34)]. They did not exhibit 
current psychiatric or neurological comorbidities. Severity of 
positive and negative symptomatology, as well as general psycho-
pathology, was assessed by the Positive and Negative Syndrome 
Scale [PANSS (35)]. In order to assess the effect of NF training on 
AVHs and affect, directly before and after the measurement on 
each day, we examined severity of the AVHs using the Auditory 
Vocal Hallucination Rating Scale [AVHRS (36)], while current 
affective state was assessed with the PANAS (37). Additionally, 
patients were interviewed about the strategies used for regula-
tion. After the measurement on each training day, they were 
asked to specify on a 10-point scale the degree of subjectively 
perceived control over their ACC activity (0 = no control at all 
and 10 = absolute control).
The patients were naïve to NF. Written informed consent was 
obtained prior to participation. The study protocol was approved 
by the Ethics Committee of the Medical Faculty of the RWTH 
Aachen University, Germany, in accordance to the Declaration 
of Helsinki.
Patient 1
Patient Demographics
The first patient was a 49-year-old woman. She had a polytechnic 
degree but was receiving early retirement pension. She had no 
partner.
Symptomatology
The patient was diagnosed with schizophrenia of the undifferenti-
ated subtype. Schizophrenia was first diagnosed 15 years ago, and 
she was continuously hearing voices since that time. Periodically, 
she also experienced tactile as well as olfactory hallucinations. 
She currently showed a mild form of paranoia (e.g., people talking 
about her). Over the years, she progressively developed a negative 
symptomatology with blunted affect, poverty of speech, and slight 
difficulties with abstract thinking (see Table 1). At the time point 
of the study, patient 1 was medicated with clozapine (450  mg/
day), aripiprazole (22.5 mg/day), and citalopram (30 mg/day) on 
a stable dose for 5 months.
Characteristics of Auditory Hallucinations (According to 
AVHRS)
Patient 1 was continuously hearing several voices simultaneously, 
often more than 10 different ones speaking at once. The voices 
were mostly commenting her behavior, affronting her, or devalu-
ing her, but there were also positive voices encouraging her. The 
patient perceived to have no control at all over the voices and 
felt moderately disturbed by them.
Patient 2
Patient Characteristics
The second patient was a 33-year-old married woman with a 
university degree in sport sciences. At the time of the study, she 
was an occupational therapist working with children.
Symptomatology
The patient was diagnosed with a schizophrenic disorder, not 
otherwise specified. She had been hearing voices for 1½ years. In 
addition to auditory hallucinations, she sometimes experienced 
olfactory hallucinations such as smelling smoke. Further, she 
reported a lifetime diagnosis of posttraumatic stress disorder 
(PTSD) and one episode of a major depression. At inclusion, 
she demonstrated symptoms neither of depression nor of PTSD. 
Positive symptomatology was moderate and negative symptoms 
were absent. The patient was not medicated at the time of the 
study (see Table 1).
Characteristics of Auditory Hallucinations (According to 
AVHRS)
At the moment of the study, the patient heard six voices that 
commented her behavior. She heard the voices at least every hour 
and reported to sometimes have control over them. She reported 
that at times, she was able to voluntarily induce pleasant voices 
by imagining activities she likes. Further, she described that she 
could sometimes stop the voices by “telling them insistently to 
shut up” or by concentrating on something else.
Patient 3
Patient Characteristics
The third patient was a young man of 24 years, with a high-
school degree. He was doing part-time jobs once in a while 
and had no partner. He was smoking about one package of 
taBLe 1 | Demographic and psychopathological information of the patients.
Gender age education  
(years)
Diagnosis 
(ICD-10)
Duration aVHs 
(years)
paNss pos. paNss neg. paNss pp. Medication
Patient 1 Female 49 18 F20.34 15 12 18 32 Yes
Patient 2 Female 33 18 F20.94 1.5 19 7 26 No
Patient 3 Male 24 10 F20.04 4 18 20 31 Yes
PANSS pos, PANSS positive score; PANSS neg, PANSS negative score; PANSS pp, PANSS general psychopathology score.
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cigarettes per day for the last 5 years. On the third day of the 
NF training, the patient stopped the measurement during the 
third NF run because he suddenly became frightened in the 
MR scanner. He heard a voice telling him to stop. Therefore, 
on the third day, we obtained data from only two NF runs and 
no posttest.
Symptomatology
Patient 3 had a diagnosis of schizophrenia of the paranoid-
hallucinatory subtype. After consuming amphetamines at a 
party 4 years before the study, he has continuously heard voices. 
He had five hospitalizations since then. During adolescence, he 
consumed a variety of drugs, but mainly cannabis and ampheta-
mines. During acute phases of the illness, he experienced visual 
hallucinations and strong paranoia as well. At inclusion, he 
was hospitalized and exhibited moderate positive and negative 
symptomatology (see Table 1). He was medicated with clozap-
ine (400 mg) for almost 2 years. The dose had not been changed 
over the last 6 months.
Characteristics of Auditory Hallucinations (According to 
AVHRS)
The patient heard five different voices that were threatening him. 
He perceived the voices as ghosts, which were talking about 
death and giving him orders. The patient felt very disturbed by 
the voices and indicated strong suffering. He reported to have no 
control at all over the voices.
experimental stimuli and task
All participants were trained to control activity in the ACC by 
means of rt-fMRI on three separate days within 1 week. On each 
day, they performed three NF training sessions, each consisting 
of eight regulation blocks and nine baseline blocks (30 s each; see 
exemplary run in Figure 1).
Change of activity in the ACC was indicated by a green bar 
moving up- or downwards, while a fixed blue bar indicated the 
baseline condition [see also Ref. (27)]. A fixed red bar in the 
regulation condition served as a regulation target. It indicated 
the upper limit of ACC upregulation. Subjects were instructed 
to raise the green bar in direction of the red bar using differ-
ent mental strategies. During the baseline blocks, participants’ 
instruction was to count backwards from 100. The feedback was 
updated every repetition time (TR; 1 s).
Before the actual NF training, all subjects participated in a 
standardized training of mental strategies for ACC self-control. 
They received standardized instructions to recall positive emo-
tional autobiographical memories, to imagine performing their 
hobby (such as engaging in sportive or musical exercise), or to 
concentrate on a specific perception (such as the temperature in 
one of their feet) in order to increase the activity in the region 
of interest (ROI). These strategies already proved effective in 
facilitating the NF training in previous studies [e.g., Ref. (32)]. 
The NF procedure was explained to subjects, including the delay 
of the NF signal for 3–5 s due to the hemodynamic response and 
data processing (<1 s).
Identical pre- and posttests assessed a possible transfer of 
the learned regulation. During these tests, subjects were asked 
to regulate their ACC activity with no feedback provided. The 
stimulus from the regulation training (i.e., the green bar) was pre-
sented during this transfer task in a fixed position. The baseline 
stimulus (blue bar) indicated the counting-backwards task. In the 
pre- and the posttest, there were four blocks of regulation and 
five blocks of baseline each. The posttest also included a cognitive 
visuospatial interference task, an adapted version of the Simon 
task, to test for generalization of the NF training to a behavioral 
task. However, single subject analysis of these cognitive interfer-
ence data were not expected to yield results and were therefore 
not analyzed. The task for pre- and posttest was programed with 
Presentation software (Version 16.3).1
1 www.neurobs.com
FIGURe 1 | example of a neurofeedback run. Blocks of regulation alternated with blocks of baseline (“counting”). During regulation blocks, the fixed red bar in 
the upper part of the screen served as a marker of the highest ACC activity as a target. The green moving bar indicated the current level of activity in the ACC, 
which should be moved toward the red bar. The baseline block was indicated by a static blue bar in the center of the screen.
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Data acquisition and analyses
Functional magnetic resonance imaging was conducted using a 
3-T whole body scanner (Magnetom TRIO, Siemens, Erlangen, 
Germany). We used a 12-channel array coil for the measure-
ments. Sixteen transverse slices parallel to anterior commis-
sure–posterior commissure (AC–PC) line were acquired with 
echo planar imaging (EPI) at a TR of 1 s (echo time TE = 28 ms; 
64 ×  64 matrix with 3  mm ×  3  mm resolution; 3-mm slice 
thickness plus 0.75-mm gap). We obtained 520 volumes for 
each NF run (about 8.5 min) and 760 volumes for the pre- and 
posttest (12.5 min). A custom anatomical template mask of the 
ACC defined our ROI [for details, see Ref. (30)]. This ACC 
mask was taken as a part of the cingulate cortex as defined 
in the WFU Pickatlas Toolbox (38) and delineated by MNI 
coordinates anterior to y = 0 and superior to z = 0, yielding a 
volume of 15.1 ml.
The feedback signal was averaged across the ACC mask for 
each volume, calculated as percentage of signal change relative 
to the preceding baseline block and scaled that 1% represented 
the full regulation width. Online processing was conducted 
using a custom toolbox based on standard SPM procedure (39). 
In short, motion correction using spline interpolation with 
co-registration to the preselected template was implemented. 
A modified Kalman filter reduced outliers and high-frequency 
fluctuations. Low-frequency drifts were removed with an 
exponential moving average algorithm to improve the signal-
to-noise ratio.
Offline data analysis was performed in SPM8 (FIL).2 The 
first 10 volumes of each run were excluded from the analyses 
accounting for T1 saturation effects. Data were realigned, 
normalized, and smoothed with an 8-mm Gaussian kernel. All 
different conditions were modeled in a block design applying 
a generic hemodynamic response function. Within a general 
linear model, T-maps for contrasts of interest (regulation ver-
sus counting, posttest versus pretest) were computed separately 
for each day and corrected for multiple comparisons across 
the volume using family-wise error (FWE) correction at a 
corrected threshold of p < 0.05 and an extended threshold of 
15 voxels.
ROI Analyses
Next to whole-brain analyses, we performed ROI analyses 
for the different contrasts of interest, first, in the target ROI, 
i.e., the ACC. Second, activations within the reward system 
measured reinforcement by the NF. These ROI masks were 
generated from the WFU Pickatlas Toolbox (38). The mask 
for the ACC was as specified above, and the reward system 
contained the putamen, the caudate nucleus, and the globus 
pallidus. We determined the peaks within both ROIs on the 
F-maps (across all runs of all days). Activations in this peak 
voxel were then plotted over the different training days and for 
the transfer conditions.
2 http://www.fil.ion.ucl.ac.uk/spm/
ResULts
Behavioral outcomes
Patient 1
Debriefing of Applied Strategies and Subjective Feeling of 
Control During NF
On the first day, patient 1 reported the strategy of imagining she was 
cycling. Additionally, she asked one of her favorite positive voices 
for help. On the subsequent days, she mainly used the strategy of 
concentrating on her positive voice and was not able to find an 
alternative strategy. Subjective feelings of control over ACC activity 
was high on the first day and decreased subsequently (see Figure 2).
Changes in AVHRS Scores
After the first training day, negative voices were perceived as less 
intense. She was better able to ignore them, felt less disturbed by 
them, and suffered less. After the subsequent two training days, 
she reported a decrease in disturbance by and suffering from 
voices. However, she felt more restricted in her concentration due 
to the voices (see Table 2).
Changes in PANAS Scores
During each training day, positive mood indicators increased. 
Negative mood also increased on the first day and remained 
constant on days 2 and 3 (see Figure 3).
Patient 2
Debriefing of Applied Strategies and Subjective Feeling of 
Control during NF
On the first day, the patient imagined pleasant activities she did 
as a child, e.g., jumping into puddles and eating ice cream. On the 
subsequent days, she shifted her strategy and tried to concentrate 
on positive childish voices. On day 3, she imagined playing the 
guitar. Over all 3  days, she perceived to have control over her 
brain activity. The patient afterward stated that she applied similar 
strategies during daily life to induce pleasant voices as well. The 
score of subjective control over ACC activity increased slightly 
from day 1 to day 2 and decreased again on day 3 (see Figure 2).
FIGURe 2 | Rating of subjective control over feedback signal across 
days. The profiles matched roughly the achieved ACC regulation (compare 
Figure 6).
March 2016 | Volume 7 | Article 376
Dyck et al. NF in AVH
Frontiers in Psychiatry | www.frontiersin.org
she reported an increase in perceived negativity of voices and a 
decrease of perceived control but also a decrease in the number 
of voices (see Table 2).
Changes in PANAS Scores
Over the first two training days, the patient reported an increase 
in positive mood and a reduction in negative mood. On the third 
day, she experienced a decrease in positive mood (see Figure 3).
Patient 3
Debriefing of Applied Strategies and Subjective Feeling of 
Control during NF
On the first training day, patient 3 reported imagining eating his 
favorite dish, thinking of holidays, meeting friends, or imagin-
ing his hand growing. On subsequent days, he repeated the 
same strategies and added imagining the exact appearance of 
his mother and friends as well as imagining the happiness when 
being discharged from the clinic. The subjective feeling of control 
over ACC activity increased from day 1 to day 2. On the third day, 
the control score decreased again (Figure 2).
Changes in AVHRS Scores
On the first and second days, he had the subjective feeling of a 
reduction of the presence and negativity of the voices during and 
shortly after the training. He also reported a decrease of suffering 
and disturbance by voices (by 5 points, respectively, on a 10-point 
scale) as well as a decrease in disturbances of concentration by 
voices. Additionally, he indicated a decrease in the number of 
voices heard (see Table 2 for exact scores).
Changes in PANAS Scores
On the first 2 days, the patient reported an increase in positive 
mood over the course of the training. Also, his negative mood 
decreased. After the break-up at the third day, he reported a 
decrease in positive mood and a strong increase in negative mood 
(see Figure 3).
taBLe 2 | aVHRs before and after neurofeedback training on days 1, 2, and 3 (improvements in bold).
patient Number of 
voices
Valence of 
voicesa
suffering from 
voicesb
Disturbance by 
voicesb
Control over 
voicesb
Fear of voicesb Disturbed concentration 
by voicesb
Day 1
Pre Post Pre Post Pre Post Pre Post Pre Post Pre Post Pre Post
1 5 5 4 5 2 1 5 1 5 5 0 0 1 2
2 3 2 5 8 2 0 1 0 4 0 0 0 0 0
3 1 1 1 5 8 3 8 3 2 2 0 0 8 5
Day 2
Pre Post Pre Post Pre Post Pre Post Pre Post Pre Post Pre Post
1 5 5 5 5 3 0 2 0 3 5 0 0 2 3
2 0 0 0 0 0 0 0 0 0 0 0 0 0 0
3 4 1 5 5 5 2 5 2 2 2 0 0 8 3
Day 3
Pre Post Pre Post Pre Post Pre Post Pre Post Pre Post Pre Post
1 3 5 5 5 3 2 5 2 5 5 2 2 5 2
2 2 0 5 0 0 0 0 0 2 0 0 0 0 0
3 1 2 5 5 2 2 2 2 2 2 1 1 7 3
aBipolar valence scale: 0 = very negative, 5 = neutral, and 10 = very positive.
bUnipolar 10-point scale: 0 = not at all and 10 = very much.
FIGURe 3 | Mood ratings according to the positive and Negative 
affect scale (paNas) before and after each neurofeedback training. 
Patient 1 exhibited a trend for continuously improved positive affect. This was 
similar in the other two participants, except that the third day was associated 
with reduced positive or increased negative affect.
Changes in AVHRS Scores
On the first day, she mainly reported a decrease in the perceived 
negativity of voices and small changes in suffering from voices 
and disturbance by voices. On the second day, there was no 
perceived change with respect to the voices, and on the third day, 
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fMRI Results
Whole-Brain Analyses
Figure  4 shows an overview of whole-brain activations on the 
three training days in the three subjects. During regulation as 
compared to the counting blocks, all patients yielded significant 
activation clusters within the ACC as well as the reward system, 
visual processing areas, the precuneus, motor areas, the amygdala, 
and the hippocampus.
ROI Analysis – ACC
Patient 1
Within the ACC mask, significant activation emerged during the 
first day (tpeak = 20.92, pFWE < 0.0001, MNI [10, 46, 6], 2474 voxels 
activated), during the second day (tpeak =  9.69, pFWE <  0.0001, 
MNI [2, 32, 10], 1496 voxels activated), and during the third day 
(tpeak = 11.16, pFWE < 0.0001, MNI [2, 34, 8], 1777 voxels activated). 
When directly comparing activation during self-regulation at the 
third and the first days, the patient did not show any significant 
activation at the ACC. At an exploratory uncorrected threshold of 
p < 0.001, one small cluster emerged in the subgenual ACC that 
was, however, not included in the ACC mask used in the training 
(MNI [10, 36, −10], tpeak = 6.88, puncorr. < 0.001, 28 voxels activated; 
see Figure 5). The overall F-test revealed peak ACC activation 
across all runs of all three training days at an anterior part of the 
ACC (Fpeak = 64.3, pFWE < 0.0001; MNI coordinate = [10, 46, 6]). 
The ACC activation at this peak voxel over the 3 days indicated 
successful ACC regulation on the first day and then decreasing 
activation over the subsequent days (see Figure 6A).
Within the transfer task – comparing activation at posttest with 
that at the pretest – patient 1 did not show any ACC activation.
Patient 2
Also in patient 2, the ACC ROI showed significant activation 
during the first day (tpeak = 13.62, pFWE < 0.0001, MNI [−6, 28, 
24], 2156 voxels activated), during the second day (tpeak = 23.13, 
pFWE < 0.0001, MNI [−2, 14, 28], 2770 voxels activated), and dur-
ing the third day (tpeak = 22.01, pFWE < 0.0001, MNI [−2, 28, 26], 
2719 voxels activated). As already indicated by the T values, ACC 
activation during the third day was significantly stronger than 
during the first day (tpeak = 10.14, pFWE < 0.0001, MNI [8, 12, −8], 
1482 voxels activated; see Figure 5). An F-test across all training 
runs revealed peak ACC activation at a relatively posterior part 
FIGURe 4 | Regulation during the neurofeedback runs as compared to baseline blocks of counting (p < 0.05, FWe corrected). The activation patterns 
did not reveal a clear increase in regulation, but the individual clusters appeared more focused on the ACC over the 3 days of neurofeedback training in patients 2 
and 3. Please note that absolute T values differ across training days and across patients (adapted color codes). However, the identical thresholds make the cluster 
sizes directly comparable.
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of the ACC (Fpeak = 133.54.3, pFWE < 0.0001; MNI [2, 16, 28]). The 
bar plot evidences an increase of ACC activation within this peak 
voxel over the first two training days and constant regulation at 
the third training day (Figure 6A).
Comparing activation of the post- and the pretest within the 
transfer task, patient 2 showed significant ACC activation (see 
Figure 7). Bar plots indicate that during the pretest, there was 
no difference in peak ACC activation between regulation and 
FIGURe 5 | Mapping of linear increase over days (p < 0.05, FWe corrected). The training led to increased activity in clusters encompassing midbrain 
structures (all patients) and – in patients 2 and 3 – in the ACC.
FIGURe 6 | Region of interest (RoI) analysis (a) in the aCC and (B) in the reward system revealed a general trend for increasing activity over the 
three training days. However, the interindividual differences are remarkable; a.u., arbitrary units.
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baseline blocks. During the posttest, there was a significant 
increase in peak ACC activation during the regulation phases and 
a slight deactivation during the baseline period.
Patient 3
Within the ACC mask, T-maps confirmed significant activation 
during the first day (tpeak = 10.66, pFWE < 0.0001, MNI [−4, 42, −8], 
717 voxels activated), during the second day (MNI [10, 26, 26], 
tpeak = 9.79, pFWE < 0.0001, 839 voxels activated), and during the 
two runs completed at the third day (MNI [8, 44, 10], tpeak = 6.4, 
pFWE < 0.0001, 352 voxels activated). When directly comparing 
ACC activation between the first two runs of the third and the 
first day, there was an increase of ACC activation (tpeak =  5.64, 
pFWE  <  0.0001, MNI [−2, 36, 28], 67 voxels activated; see 
Figure 5). The F-test across all training runs revealed peak ACC 
activation at a relatively posterior part of the ACC (Fpeak = 23.28.3, 
pFWE < 0.0001; MNI [6, 24, 28]). Bar plots indicate that peak voxel 
activation increased from the first to the second day. On day 3, 
decrease may be observed (see Figure 6A).
The third patient finished the third training day earlier, and no 
data of the posttest are available; thus, we could not calculate the 
transfer effect for this patient.
ROI Analysis – Reward System
Patient 1
The overall F-test shows activation in four different clusters with 
peak activation at the MNI coordinate [12, 16, −10]. Inspecting 
activation within this peak voxel over the three training days 
indicated reward system activation on the first day and almost no 
activation during the second and the third days (see Figure 6B). 
When directly comparing activation of day 3 and day 1 within 
the ROI mask, significant activation could only be shown in a 
small cluster in the left putamen (MNI [−22, 14, −10], tpeak = 8.80, 
pFWE < 0.0001, 68 voxels activated; see Figure 5B).
Patient 2
With respect to the reward system, the F-test shows activation in 
two clusters with the peak activation at the MNI coordinate [24, 
6, 0]. Activation in this peak voxel across training days showed 
a very similar increase as the ACC. A direct comparison of ROI 
activation at day 3 and day 1 indicated significant bilateral activa-
tion (tpeak = 13.23, pFWE < 0.0001, MNI [−32, 2, −6], 3331 voxels 
activated; see Figure 6B).
Patient 3
The F-test shows bilateral activation with peak activation at the 
MNI coordinate [34, −18, −2]. Bar plots showed similar bilateral 
activation increases from day 1 to day 2 and a drop in activation 
on day 3. Comparing activations of day 2 and day 1 with T-maps 
indicated a significant activation increase (MNI [28, −16, 4], 
tpeak = 6.66, pFWE < 0.0001, 231 voxels activated; see Figure 6B).
DIsCUssIoN
We demonstrated the feasibility of fMRI-based NF training in 
patients with ongoing AVHs. After the NF training, the patients 
reported varied degree of subjective improvement concerning 
disturbance through and suffering from voices, as well as decrease 
in their number, intensity, and negativity. In combination with 
previous studies employing the same paradigm, the data suggest 
that patients with schizophrenia can learn localized control of 
ACC activity as well. For the patients suffering from treatment-
resistant hallucinations for years despite intensive multimodal 
treatment, this new approach may change their understanding of 
AVHs, offering subjective experience of control over the voices. 
Nevertheless, even those three patients exhibited remarkable 
individual response patterns suggesting the need for a careful 
patient and paradigm selection for future clinical trials. More 
studies are necessary to assess the clinical relevance of fMRI NF, 
possibly in combination with other therapeutic techniques such 
as cognitive behavioral therapy.
The heterogeneity between the patients was also reflected 
in individually differing brain networks that were activated 
during NF. When evaluating mood changes across the NF 
training, the regulation training led to increased positive 
FIGURe 7 | transfer effect in patient 2 (p < 0.05, FWe corrected). ACC regulation emerged also in the absence of feedback after the NF training as compared 
to before. However, the ACC activation cluster was noticeably smaller than during the neurofeedback training (see Figure 3) and did not yield significance in patient 
1. The strong activation changes in the visual system may be related to attention shifts with respect to the visual task.
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affect on the first and second days such as in a previous study 
with 1-day training (27). However, the participants did not 
profit from the prolonged three-session training. Indeed, 
in one subject, we even observed deterioration on the third 
day. Similarly, Surmeli et al. (18) demonstrated in their EEG-
based NF study variability both in training duration and in 
clinical outcome. The authors postulate that every EEG-NF 
treatment protocol should be personalized to the specific 
patient and be regularly monitored and adjusted for an opti-
mum treatment effect. The National Advisory Mental Health 
Council’s Workgroup (40) urged to search for personalized 
therapy, based on the knowledge about the individual that 
differentially predicts his or her response to treatment.
psychopathology and Neurofeedback
Personalization of treatment may be of particular interest con-
sidering the high interindividual variability between patients 
with schizophrenia that goes along with variability in individual 
activations patterns in the current study. In fact, the three patients 
measured in the current study showed high variability: next to 
differences in the exact diagnosis and duration of illness, also 
extrinsic factors, such as “secondary” negative symptoms, addi-
tional lifetime diagnosis of depression, and drug-related changes, 
may have caused further variability within the schizophrenia con-
tinuum. In accordance with the Report of the National Advisory 
Mental Health Council’s Workgroup (40), we describe below 
case-oriented results in hope that they provide a more stratified 
approach for linking psychopathology to treatment outcome and 
will complement standard clinical trials.
patient 1
Patient 1 showed successful regulation already in the first run 
of the first day but failed to increase the ACC activation over 
the course of training. The patient’s symptoms were concordant 
with a deficit form of schizophrenia, i.e., schizophrenia with 
primary and enduring negative symptoms (41, 42). This patient 
presented a long duration of illness with symptoms being stable 
over time. Additionally, she was the only patient treated with a 
highly D2-affine antipsychotic (aripiprazole). Negative symp-
toms and antipsychotic medication were found to be associated 
with reduced reward system sensitivity (43). Indeed, this patient 
exhibited much lower reward system activation during NF 
in comparison to the other two patients. In a previous animal 
study, reward system involvement was confirmed an obligatory 
requisite for learning to control BCIs (44). Although NF strongly 
relies on operant conditioning (16) and, therefore, on an adequate 
perception of rewarding events and appropriate reactions to 
rewards, the patient regulated ACC activity and demonstrated a 
consistent clinical improvement on all training days. Moreover, 
her subjective feeling of control over the ACC corresponded to 
actual ACC activity. Because negative symptoms in schizophrenia 
are often associated with attention deficits, it may also have been 
difficult for the patient to adopt, maintain, and shift the cognitive 
strategies as indicated by the feedback signals. This may explain 
why she did not show increasing ACC activation over the training 
and shifted from a successful regulation strategy on day 1 to less 
effective strategies on the subsequent days.
Auditory verbal hallucination symptoms showed a relatively 
close match with the training success on the 3  days [average 
blood-oxygen-level dependent (BOLD) effect in ACC]. Thus, the 
change in the AVH symptoms may also serve as a performance 
indicator and probably even stronger reward than the feedback 
from the bar display. Hence, future studies may probe to what 
extent strongly anhedonic patients profit from the instruction 
to consider an increase of the feedback signal and additionally 
explore specifically strategies to modify the depicted neuronal 
activity based on their AVHs.
patient 2
Patient 2 demonstrated both an increase of the ACC activation 
during NF from the first to the third day and a significant ACC 
upregulation in the transfer condition without feedback. These 
changes were accompanied by changes in the perception of her 
AVHs as well as changes in mood. While ACC activity increased 
on days 1 and 2 with concurrent improvements in the disturbance 
of AVHs, high activity on day 3 seemed to elucidate a trade-off 
between a decrease in the number of voices, an increase in the 
perceived negativity of the voices, and a decrease in mood. Insofar, 
the results from patient 2 do not show a clear correspondence 
between ACC activity and symptom experience on the third day 
but suggest that, at least for this patient, other brain circuitries 
may be required to yield constant effects on AVHs and mood. On 
the neuronal level, there was stronger concurrent activation of 
the anterior prefrontal cortex and left subgenual ACC at the first 
2 days when compared to the third day. On day 3, in contrast, 
there was increased activation of the inferior frontal gyrus and 
insula. Thus, the improvement in AVH symptoms on the first 
days may have been due to an additional increase of prefrontal 
inhibition or prefrontally mediated focusing on the task (45–47). 
This patient might profit from feedback derived from several 
frontal brain areas or connectivity between the ACC and the 
anterior prefrontal cortex in order to achieve more stable effects 
of NF on symptomatology.
Importantly, after the NF training, this patient managed to 
upregulate her ACC even without receiving feedback. She was 
the only patient to show this transfer effect, which may be due 
to the fact that she already used similar strategies for the control 
of her voices before the study. If this transfer mechanism shows 
to be stable in the long term, it would allow voluntary control 
over AVHs also outside the scanner. Further, this finding would 
additionally strengthen long-term NF effects that may be due 
to neural plasticity (48). In a NF study with a small number of 
schizophrenia patients, Ruiz et al. (17) demonstrated this transfer 
effect on a trend level. In addition to increasing the number of 
patients, variability of patient characteristics should be consid-
ered in future studies.
patient 3
Patient 3 increased ACC regulation over the first two training days. 
These neuronal changes were accompanied by mood improve-
ments as well as relevant changes in the perception of the AVHs. 
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On day 3, he showed a decrease of ACC activation as well as a 
decrease in mood and no further perceived symptom reductions. 
Moreover, his subjective feeling of control over the ACC activity 
corresponded well with the actual ACC activity. Further, ACC 
activations were closely associated with the reported symptoms. 
However, this patient stopped the measurements on day 3 due 
to increased anxiety and warning of his voices. This leads to the 
question, if such “negative therapeutic response” (49) is an effect 
to consider in the NF treatment of AVHs. Indeed, many patients 
report AVHs as being at least in parts positive and helpful [e.g., 
Ref. (50)]. In combination with a growing fear to change positive 
aspects of the disorder, it needs to be considered whether 3 days of 
intensive rt-fMRI NF training within 1 week may be too exhaust-
ing for schizophrenia patients with complex symptoms. When 
inspecting the data, it seems that a 2-day training would have 
resulted in a comparable outcome. Conceivably, some patients 
might better profit from additional booster sessions of NF train-
ing some weeks later.
Models of auditory Verbal Hallucinations
Several theories have been put forward to explain the occurrence 
of AVHs and link them to observed neuronal changes. The feed-
forward model being one of the most influential [for a review, 
see Ref. (3, 51)]. This neurocognitive model poses that AVHs 
occur due to a failure to recognize self-generated inner speech 
(51). The aberrant corollary discharge (or efferent copy) prevents 
comparing information about predicted action with received 
sensory input (52, 53). Consequently, self-generated speech is 
interpreted as externally generated (3, 54–57). Corresponding 
to the feed-forward model, patients with AVHs show systematic 
biases in motor tasks and pronounced deficits in cognitive tasks 
assessing self-recognition (58, 59). Indeed, connectivity was dis-
rupted between temporal and cingulate cortices in schizophrenia 
patients with AVH only (60), and AVHs severity correlated to 
functional connectivity between the ACC and the STG (61). 
Contrary to patients with AVH, in healthy controls and in schizo-
phrenia patients without AVH, the connectivity between left STG 
and the ACC (60) or the mPFC (62) was significantly greater for 
other – than for self-generated speech. Conceivably, in addition 
to structures, such as the STG, the ACC plays a central role in 
symptom generation and intensity modulation of AVHs.
However, the feed-forward model fails to explain phenom-
enological aspects of AVHs. For instance, most hallucinations 
are experienced as located in external space and take the form of 
another person’s voice, usually being experienced as “alien” (63). 
Cho and Wu (64, 65) pointed out that the internal articulation 
typically lacks properties associated with the experience of pitch 
and timbre distinct from one’s own voice, and they propose to 
replace the self-monitoring theory with the concept of auditory 
imagery as underlying phenomenon for AVH. AVH could also 
be linked to an externalizing bias in reality monitoring, which 
results in an impaired ability to distinguish between internally 
generated and externally generated percepts (66). Further, Waters 
et al. (67) conceptualizes AVHs as memory intrusions that are not 
recognized as such because they lack contextual cues. Another 
model attributes the emergence of AVHs to the highly increased 
salience of internal representations in schizophrenic patients that 
may be mediated by abnormal dopamine levels (68, 69). Hoffman 
et al. (70) proposes that prepsychotic social withdrawal prompts 
neuroplastic reorganization by the “social brain” to produce spu-
rious social meaning via hallucinations of conversational speech. 
This diversity of models renders it difficult to select a fitting target 
region for voluntary brain regulation. Although most of the fMRI 
studies point to STG or auditory cortices as an evident target for 
downregulation (24, 25), it is not clear whether these areas can be 
downregulated to achieve a relevant physiological effect. Further, 
the downregulation of a sensory area would be equivalent of 
directing the attention away from a sensory channel, which 
patients already unsuccessfully tried before. It will be interested 
to target those regions in future fMRI NF studies to assess their 
feasibility and compare with the regulation of the ACC.
Previous NF studies demonstrated that the upregulation of a 
single area can elicit alterations of functional and effective con-
nectivity (48, 71). Further studies may elucidate whether the ACC 
upregulation also induces changes of the network dynamics. In 
the long term, it may be even more effective if NF would target 
further areas and aim at a correlated regulation. First, this would 
allow addressing the entire dysfunctional neuronal ensemble 
that predisposes AVHs (3). And second, it would enable to adjust 
activity of the proposed salience network that may be of impor-
tance in the change of AVHs (72, 73).
other Neuromodulation strategies
Despite the lack of hard evidence, EEG-based NF has been estab-
lished in clinical domains such as attention deficit hyperactivity 
disorder (74) and epilepsy (75). For the application of EEG-based 
NF in schizophrenia, only case studies are available [e.g., Ref. 
(18)]. In general, these approaches are based on quantitative EEG, 
i.e., they attempt a “normalization” of oscillatory activity during 
resting state. This technique is widely available and relatively 
cost-effective. However, the training takes weeks to months [e.g., 
the average of 58.5 training sessions in Ref. (18)]. This is in an 
interesting difference to fMRI-based approaches. In our study 
and others [e.g., Ref. (76, 77)], successful control with fMRI-BCI 
tended to emerge extremely fast or even abrupt. It is unclear where 
this difference emerges from. Potentially, the precise localization 
supported by the modular organization of brain function enables 
a more direct control of the localized BOLD signal rather than 
EEG activity from distributed sources.
Alternatively, external neuromodulation strategies are avail-
able. In AVHs, particularly TMS has been applied. Typically, 
using repetitive stimulation to reduce local brain activity, rTMS 
studies targeted left temporoparietal cortex (10). Nevertheless, 
treatment success has been mixed, and improvements, such as 
localization based on fMRI activation maps, have been suggested 
(78). Moreover, TMS is limited to targets close to the surface; 
therefore, fMRI-based NF is ideally suited to base the target 
ROIs on such navigator [compare Ref. (79) for this strategy in 
depression]. The current study applied a predefined ROI of (parts 
of) the ACC. This region could not be addressed by TMS due to 
its anatomical localization. Indeed, such extended regions would 
not be assessable even to deep brain stimulation [DBS; see Ref. 
(80) for application in depression]. Finally, transcranial direct 
current stimulation (tDCS) is rather limited in targeting specific 
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anatomical structures and to our knowledge has not been applied 
in AVHs yet. The combination of different neuromodulation 
strategies seems promising to optimize modulation strength, 
localization, and long-term effects, e.g., a combination of TMS 
and EEG-NF showed promising effects in autism (81). Such strat-
egies could encompass TMS to localize the optimal modulation 
location, fMRI-NF to achieve rapidly a regulation strategy, and 
EEG-NF to maintain the learning effect over long term.
Limitations
The most prominent limitation of the study is the small number 
of patients that does not allow for generalizing the findings to 
populations. However, the study is not aimed at demonstrating 
effectivity of the NF treatment or even making treatment sug-
gestions. No systematic catamnesis was assessed because we 
did not expect persistent clinical affects from the one-time NF 
intervention. The study only provides evidence for the feasibil-
ity of ACC NF in patients with ongoing AVHs. The observed 
variability of clinical findings and the approaches to the feedback 
training offers information for the design of systematic studies, 
in particular clinical trials. It seems relevant to consider factors 
interfering with reward processing such as anhedonia and antip-
sychotic medication. Conceivably, the drug treatment alters the 
neuroplasticity or the ability to learn NF. Indeed, such a group 
of treated patients showed a different pattern in the learning 
of ACC regulation but quantitatively were as capable to learn 
ACC NF as matched controls (32). However, antipsychotics 
will be present in virtually all groups of schizophrenia patients 
with treatment-resistant AVHs. The effort for the patients to 
undergo the NF training should not be underestimated as well 
as the mixed motivation of the patients, since there are often 
also positive aspects of the hallucination, which the patients may 
fear losing after the training. Particularly, we cannot exclude the 
non-specific influence of undergoing the procedure, since there 
was no control patient group (e.g., who learned the control of a 
different brain region).
Further, no formal long-term follow-up was conducted with 
the patients, which is underrepresented in fMRI-BCI research 
in general (17, 71). In informal reassessments during clinical 
visits, none of the patients reported adverse effects and two of the 
patients claimed to have different strategies in dealing with their 
AVHs up to few weeks after the training. However, in contacts 
more than a month after the study, none of the patient had the 
impression that there was any influence on their symptoms. 
Individual variability and fluctuation in the disease course may 
override the – so far rather small – effects of the NF training. This 
may change with better targeted NF protocols. However, based on 
the clinical impression, we would suggest that at least monthly 
reminder session would be advisable for clinical trials.
Finally, other neural networks may serve as target for the NF 
training. The current pilot study did not compare the regulation of 
the ACC with other regions. Thus, unspecific processes may have 
engaged the ACC during the regulation attempts and contributed 
to the observed activation pattern. In particular, performance 
monitoring and related psychological functions may yield base-
line activation during the regulation blocks. Nevertheless, NF is 
thought to – at least – increase these activations [e.g. Ref. (27)]. 
Further, experimental trials or case studies may be directed to 
alternative regulation targets in AVH. In particular, the auditory 
cortex may be an important target for downregulation [see Ref. 
(81)], but so far, there is little experience in self-regulation of 
these areas with fMRI-NF [see review in Ref. (82)].
CoNCLUsIoN
We explored the application of fMRI-based NF in therapy-
resistant AVHs. Three patients suffering from AVHs due to 
schizophrenia trained the self-regulation of ACC activity. In gen-
eral, they achieved control of areas encompassing the ACC, and 
in one patient, the transfer of regulation to a condition without 
NF could be shown. Further regulation success was associated 
with changes in symptom scores. However, variability of disease 
presentation and antipsychotic medication was reflected in the 
individual repose patterns. These data should inform future NF 
studies in AVHs; among others, such trials need to take into 
account individual differences in reward processing, fatigue, and 
motivation.
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